-
CPHI China opens for international partnering after China rises in CPHI Index
Market news
PharmaSources.comJune 08, 2022
CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see increases in all categories of the most recent CPHI Pharma Index.
-
InnoCare Announces Priority Review of Orelabrutinib for the Treatment of R/R MZL by NMPA
Market news
PharmaSources.comSeptember 06, 2022
So far, no BTK inhibitor has ever been approved for treating patients with R/R MZL in China, and hope that orelabrutinib can fill the gap in this therapeutic area.
-
Latest Data of InnoCare’s Robust Oncology Pipelines Presented at the 2022 ASCO Annual Meeting
Market news
PharmaSources.comJune 07, 2022
Latest data of InnoCare’s robust oncology pipeline were presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.
-
Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry
Market news
PharmaSources.comMay 05, 2022
Avantor announced it will create a new manufacturing and distribution Hub in Singapore.
-
ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and Middle-Income Countries
Market news
PharmaSources.comApril 12, 2022
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
-
Rokote Laboratories selects Exothera for GMP manufacturing of its second-generation coronavirus vaccine FINCoVac 2.0.
Market news
PharmaSources.comApril 07, 2022
Rokote Laboratories Finland Ltd., a vaccine development company focusing on a second-generation COVID-19 vaccine, and Exothera S.A. will collaborate to bring the intranasal coronavirus vaccine FINCoVac 2.0 to clinical Phase I/II trials.
-
FDA Inspections of Outsourcing Facilities
Market news
FDAMarch 31, 2022
Provide an overview of the inspection process for compounding outsourcing facilities.
-
LianBio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Market news
LianBioMarch 31, 2022
LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets...
-
InnoCare Announces Dosing of First Patient in Clinical Trial of RTK Inhibitor ICP-033 in China
Market news
PharmaSources.comMarch 30, 2022
InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases...
-
Rentschler Biopharma and Vetter Unveil Xpert Alliance, a Joint Visualization of their Successful Strategic Collaboration
Market news
b3cnewswireMarch 30, 2022
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations...
CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see increases in all categories of the most recent CPHI Pharma Index.
So far, no BTK inhibitor has ever been approved for treating patients with R/R MZL in China, and hope that orelabrutinib can fill the gap in this therapeutic area.
Latest data of InnoCare’s robust oncology pipeline were presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.
Avantor announced it will create a new manufacturing and distribution Hub in Singapore.
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Rokote Laboratories Finland Ltd., a vaccine development company focusing on a second-generation COVID-19 vaccine, and Exothera S.A. will collaborate to bring the intranasal coronavirus vaccine FINCoVac 2.0 to clinical Phase I/II trials.
Provide an overview of the inspection process for compounding outsourcing facilities.
LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets...
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations...
Pharma Sources Insight JUNE2022
